newsfilter
← Latest News
GlobeNewswire·

PharmaTher Announces Update on FDA New Drug Application for Ketamine

FDA granted a post-complete letter clarification meeting scheduled for December 2, 2024 Company initiated activities to address the deficiencies cited in the CRL TORONTO, Nov. 19, 2024 (GLOBE NEWSWIRE) --